Welltower (WELL) Heads Into Earnings On A Funding Edge With Fair Value In Focus

Earnings focus on Welltower as REITs adjust to higher yields

Attention is building around Welltower (WELL) as investors prepare for its upcoming quarterly earnings update and weigh sector commentary about its funding edge while rising Treasury yields slow broader REIT deal activity.

Welltower’s share price has eased in recent weeks, with the stock down 3.96% over seven days and 6.37% over the past month. However, the year-to-date share price return of 18.28% and a 1-year total shareholder return of 32.66% point to momentum that has built over a longer stretch. This is supported by a 3-year total shareholder return of 173.23% and 5-year total shareholder return of 199.26% at a latest share price of US$221.12, as investors reassess its funding advantage against the broader REIT sector’s slower deal activity.

Scan other potential winners benefiting from similar funding tailwinds by reviewing our curated list of 31 resilient stocks with low risk scores alongside Welltower’s upcoming earnings story.

Welltower looks like a powerful senior housing platform, yet the recent pullback after a strong multi year run raises a simple issue. Does the current US$221 share price still give you enough value for that quality?

Most Popular Narrative: 16% Undervalued

On the widely followed narrative, Welltower’s fair value sits at $262.05 compared with the latest $221.12 close. This frames the current debate around how much senior housing growth and capital recycling can support that gap.

Significant off market acquisition activity, with about US$15.5b of largely newer senior housing assets bought or under contract at discounts to replacement cost and with room for occupancy improvement, gives Welltower a pipeline of properties that can contribute to future revenue and NOI expansion as they stabilize.

See why 28 investors see Welltower as 16% undervalued.

Result: Fair Value of $262.05 (UNDERVALUED)

Still, the story around Welltower can change quickly if the 11 billion of recent asset sales remain dilutive for a longer period or if governance concerns begin to constrain fresh equity raising.

Find out about the key risks to this Welltower narrative.

Another View on Welltower’s Valuation

That 16% “undervalued” fair value story leans heavily on long term earnings projections. A simpler yardstick tells a very different story. On a P/E of 102.8x versus a Global Health Care REITs average of 17.1x and a fair ratio of 39.9x, Welltower screens as heavily priced, which raises an obvious question: Is the quality of the senior housing platform strong enough to justify paying almost triple that fair ratio?

For a closer look at how those earnings multiples line up against the underlying fundamentals, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed messages around Welltower’s valuation and quality are clear, so treat this moment as a prompt to review the data yourself and move quickly. To weigh the upside against the concerns in detail, take a look at the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Welltower?

If you want a fuller picture than any single REIT can offer, broaden your watchlist now and let data driven ideas surface opportunities you might otherwise miss.

• Target resilience first by reviewing a list of solid balance sheet and fundamentals (25 results) that can help you focus on companies where balance sheets and fundamentals carry most of the weight.
• Hunt for potential mispricings by scanning a 20 high quality undiscovered gems that highlights under followed businesses with strong financial characteristics.
• Dial up defense in uncertain markets by filtering a 8 dividend fortresses built around higher yielding dividend payers with an emphasis on durability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com